FDA Asked to Consider Party Drug MDMA as Treatment for PTSD
WEDNESDAY, Dec. 13, 2023 (HealthDay News) — A California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stress disorder (PTSD). When announcing the new drug application (NDA) filing on Tuesday, MAPSContinue Reading